O10.05 FINAL ANALYSIS OF THE BELOB TRIAL (A RANDOMIZED PHASE II STUDY ON BEVACIZUMAB VERSUS BEVACIZUMAB PLUS LOMUSTINE VERSUS LOMUSTINE SINGLE AGENT IN RECURRENT GLIOBLASTOMA) AND FIRST RADIOLOGY REVIEW RESULTS

Saved in:
Bibliographic Details
Published in:Neuro-oncology (Charlottesville, Va.) Va.), 2014-09, Vol.16 (suppl 2), p.ii24-ii24
Main Authors: Taal, W., Oosterkamp, H. M., Walenkamp, A. M. E., Dubbink, H. J., Beerepoot, L. V., Hanse, M., Buter, J., Honkoop, A., Boerman, D., Vos, F. Y. F., Dinjens, W. N. M., Enting, R. H., Taphoorn, M. J. B., van den Berkmortel, F. W. P. J., Jansen, R., Brandsma, D., Bromberg, J. E., van Heuvel, I., Vernhout, R. M., van der Holt, B., van den Bent, M. J.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1522-8517
1523-5866
DOI:10.1093/neuonc/nou174.86